Compare Incyte Corporation (INCY) vs Vistra Corp (VST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Incyte Corporation vs Vistra Corp — how do they compare? Incyte Corporation trades at $112.79 (market cap $22.85B), while Vistra Corp trades at $161.48 (market cap $52.41B). The key difference: Vistra Corp is far larger — about 2.3× Incyte Corporation's market cap, and Vistra Corp pays a 0.59% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Incyte Corporation for 33 Days and Vistra Corp for 32 Days on average.
| INCY | VST | |
|---|---|---|
Market Cap | $22.85B | $52.41B |
Volume | 1,927,029 | 11,278,074 |
Sector | Health | Utilities |
52-Week High | $129.93 | $210.85 |
52-Week Low | $83.80 | $134.71 |
Typical Hold Time | 33 Days | 32 Days |
Enterprise Value | $18.35B | $74.34B |
Dividend Yield | — | 0.59% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Incyte (INCY) trades at $112.75, down 0.61% today, with a bearish technical signal but strong fundamentals. The stock shows robust profitability with a 27.71% net income margin and 30.67% ROE. Recent news includes FDA approval for Atebrioz and expansion of its inflammation portfolio, supporting growth beyond its key drug JAKAFI. Revenue grew to $5.14 billion in 2025, with net income surging to $1.29 billion, reflecting improved operational efficiency.
The outlook is positive with a consensus price target of $132.43, implying 17% upside, though near-term earnings pressure and JAKAFI's patent expiry after 2029 pose risks. Analyst sentiment is bullish (52% buy ratings), but technical indicators suggest caution with key support at $111. Execution on pipeline diversification remains critical for sustained growth.
Vistra Corp. (VST) trades at $156.14, down 6.35% on the day, with a mixed earnings history including a recent Q1 2026 beat but Q4 2025 and Q2 2026 misses. The stock shows strong profitability with an 11.55% net income margin and 75.73% ROE, while technical indicators signal a bullish trend with support at $152 and resistance at $164. Recent news highlights a $4.2 billion US loan for nuclear power expansion and a 20-year power deal with New Era Energy, positioning Vistra to capitalize on AI-driven electricity demand.
Vistra's outlook is positive, driven by nuclear power expansion and data center energy contracts, with a consensus price target of $215.23 implying 38% upside. Risks include earnings volatility, high debt levels, and regulatory uncertainties, but strong analyst support (91.3% buy ratings) and institutional interest from investors like Peter Thiel underscore growth potential in the AI power infrastructure sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Incyte Corporation
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →About Vistra Corp
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →
